Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
To treat Candida albicans, a common yeast that can cause illness in those with weakened immune systems, researchers limited the fungus’ access to iron, an element crucial to the organism’s survival.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy.”Mira Edgerton, research professor in the Department of Oral Biology at the UB School of Dental Medicine
They did so by using deferasirox, a medication used to treat blood disorders. Tested in mice, the results were promising: investigators decreased iron levels in saliva by four times, which altered the expression of more than 100 genes by the fungus, diminished its ability to infect oral mucosal tissue and caused a two-fold reduction in the organism’s survival rate.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy,” says Mira Edgerton, DDS, PhD, co-lead investigator of the study and research professor in the Department of Oral Biology at the UB School of Dental Medicine.
Edgerton, along with Sumant Puri, PhD, co-lead investigator and assistant professor in the Kornberg School of Dentistry at Temple University, published the study in March in Antimicrobial Agents and Chemotherapy.
Currently, only three major classes of clinical antifungal drugs exist. However, fungal drug resistance has steadily increased and no new classes of antifungals have emerged in decades, says Edgerton.
Candida albicans, a fungus among the group building resistance, is the agent behind a number of infections. They include oral thrush, a yeast infection in the mouth identified by a white film that coats the tongue and throat, causing painful swallowing; and denture-related stomatitis, a fungal infection that affects nearly two-thirds of U.S. denture wearers that causes inflammation, redness and swelling in the mouth.
The yeast is also the fourth leading cause of hospital-acquired bloodstream infections, which often have high mortality rates, says Edgerton.
Candida albicans is the most abundant fungus in the oral microbiome and relies heavily on saliva as a source for essential elements. Iron, the second most abundant metal in saliva, is a critical nutrient used by the fungus in several cellular processes, including energy production and DNA repair.
In mice, the group added deferasirox to drinking water to lower iron levels in saliva and reduce the availability of iron needed to sustain an infection.
The investigators found that Candida albicans in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 percent survival rate compared to a 25 percent survival rate in mice who did not receive the treatment.
The therapy also altered the expression of 106 genes by the fungus, a quarter of which were involved in the regulation of iron metabolism, directly regulated by iron or had iron-related functions. The study is the first report of iron starvation affecting gene expression of Candida albicans in real time during live infection, says Puri.
Other research has shown that treatment with deferasirox does not result in iron deficiency in adults with normal iron levels, forming the potential for preventative treatment for those who are also vulnerable to mucosal infections, says Puri.
The Latest on: Drug-resistant fungal infections
via Google News
The Latest on: Drug-resistant fungal infections
- Drug-resistant infections: If you can’t beat ‘em, starve ‘em, scientists findon March 16, 2020 at 5:00 pm
BUFFALO, N.Y. — How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers. To ...
- Researchers forge a new weapon to fight parasites and other infectionson March 12, 2020 at 7:07 am
He plans to expand the project through a collaboration with professor Clarissa Nobile, who examines Candida auris, a fungal infection that has made headlines in the past few years as hospitals ...
- SCYNEXIS Reports Full Year 2019 Financial Results and Provides Company Updateon March 11, 2020 at 5:19 am
Oral ibrexafungerp continues to advance in multiple indications Nearing completion of Phase 3 VANISH program, evaluating oral ibrexafungerp for the ...
- SCYNEXIS Reports Full Year 2019 Financial Results and Provides Company Updateon March 10, 2020 at 5:00 pm
We believe ibrexafungerp has the potential to become a leading antifungal therapy in both ... and prevent difficult-to-treat and drug-resistant infections. Our lead candidate, ibrexafungerp ...
- UC Merced Connect: Researchers forge a new weapon to fight parasites, other infectionson March 8, 2020 at 6:00 am
Breakthrough collaborative science by an interdisciplinary team of researchers brought together by UC Merced computational biology Professor David Ardell promises a new approach for treating all types ...
- Fungal Infectionson November 30, 2019 at 3:09 pm
Amphotericin B (AmB) is the drug of choice for progressive and potentially life-threatening fungal infections of the abdomen and heart valves, fungal pneumonia, and leishmaniasis, a neglected ...
- Deadly, drug-resistant fungus raising alarms among health expertson April 12, 2019 at 3:42 pm
Fungal infections are often caused by microscopic fungi common in the environment. Fungi live outdoors in soil and on plants as well as on many indoor surfaces and on human skin. Fungal infections ...
- CDC warns about mysterious "superbug" funguson April 10, 2019 at 8:38 am
A mysterious drug-resistant fungal infection has sickened hundreds of people in the U.S. in recent years. Dr. Neeta Ogden joins CBSN to discuss where this infection comes from and why it's spreading.
- Drug-Resistant Fungal Infection Spreading Across Tri-State Hospitalson April 8, 2019 at 3:51 pm
Candida auris, a yeast fungus, was only discovered in 2009 but has quickly spread globally. When it comes to the United States and here in our area, the CDC says New York has 309 confirmed cases ...
- Genetic target could help fight deadly drug-resistant infectionson March 18, 2019 at 12:25 pm
COLUMBUS, Ohio – Fungal infections pose a major threat to hospital patients and have proven difficult to combat, but scientists have unlocked evidence that could lead to more effective treatment.
via Bing News